Antitumor granuloma formation by CD4+ T cells in a patient with rapidly progressive melanoma experiencing spiking fevers, neuropathy, and other immune-related toxicity after treatment with ipilimumab

Journal of Clinical Oncology

Volumn 33, Issue 6, 2015, Pages e32-e35

  Luke, Jason J ^a   Lezcano, Cecilia ^a   Hodi, F Stephen ^a   Murphy, George F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GABAPENTIN; GLUTAMINE; IPILIMUMAB; MELAN A; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PETHIDINE; PREDNISOLONE; PROTEIN S 100; MONOCLONAL ANTIBODY;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AXILLARY LYMPH NODE; AXILLARY MASS; BELL PALSY; BODY TEMPERATURE; BURNING SENSATION; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CERVICAL LYMPHADENOPATHY; CODON; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CYTOKINE STORM; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ELECTROMYOGRAPHY; EMERGENCY WARD; FACE ASYMMETRY; FEMALE; FEVER; GENE; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MELANOMA; METASTATIC MELANOMA; MIDDLE AGED; MUTATIONAL ANALYSIS; NRAS GENE; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; POINT MUTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN TINGLING; T LYMPHOCYTE; UNSTEADINESS; UVEITIS; VISUAL DISORDER; WIDE EXCISION; WILD TYPE; CHEMICALLY INDUCED; GRANULOMA; IMMUNOLOGY; PATHOLOGY;

ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FEVER; GRANULOMA; HUMANS; MELANOMA; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84923165576     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.7735     Document Type: Article

References (25)

1. Spatz A, Gimotty PA, Cook MG, et al: Protective effect of a brisk tumor infiltrating lymphocyte infiltrate in melanoma: An EORTC melanoma group study. J Clin Oncol 25:476s, 2007 (suppl; abstr 8519)
2. Clemente CG, Mihm MC Jr, Bufalino R, et al: Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303-1310, 1996
3. Pardoll DM: The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252-264, 2012
4. Peggs KS, Quezada SA, Korman AJ, et al: Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr Opin Immunol 18:206-213, 2006
5. Yuan J, Ginsberg B, Page D, et al: CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: Three cases. Cancer Immunol Immunother 60:1137-1146, 2011
6. Di Giacomo AM, Danielli R, Guidoboni M, et al: Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: Clinical and immunological evidence from three patient cases. Cancer Immunol Immunother 58:1297-1306, 2009
7. Coyne JD: Necrobiotic palisading granulomas associated with breast carcinoma. J Clin Pathol 58:1290-1293, 2005
8. Bässler R, Birke F: Histopathology of tumour associated sarcoid-like stromal reaction in breast cancer: An analysis of 5 cases with immunohistochemical investigations. Virchows Arch A Pathol Anat Histopathol 412:231-239, 1988
9. Ophir D, Nissim F, Marshak G: Granulomatous reaction in lymph nodes draining laryngeal carcinoma. Head Neck Surg 8:214-217, 1986
10. Kamiyoshihara M, Hirai T, Kawashima O, et al: Sarcoid reactions in primary pulmonary carcinoma: Report of seven cases. Oncol Rep 5:177-180, 1998
11. Shigematsu H, Kurita A, Omura Y, et al: Gastric cancer with sarcoid reactions in the regional lymph nodes, the stomach wall, and the splenic parenchyma: Report of a case. Surg Today 29:549-552, 1999
12. Coyne JD: Colonic carcinoma with granulomatous (sarcoid) reaction. J Clin Pathol 55:708-709, 2002
13. Fujii T, Tabe Y, Yajima R, et al: Adenocarcinoma of ascending colon associated with sarcoid reaction in regional lymph nodes. Case Rep Gastroenterol 4:118-123, 2010
14. Gregorie HB Jr, Othersen HB Jr, Moore MP Jr: The significance of sarcoid-like lesions in association with malignant neoplasms. Am J Surg 104:577-586, 1962
15. Brincker H: Sarcoid reactions in malignant tumours. Cancer Treat Rev 13:147-156, 1986
16. Sneller MC: Granuloma formation, implications for the pathogenesis of vasculitis. Cleve Clin J Med 69:SII40-SII43, 2002 (suppl 2)
17. Tomimaru Y, Higashiyama M, Okami J, et al: Surgical results of lung cancer with sarcoid reaction in regional lymph nodes. Jpn J Clin Oncol 37:90-95, 2007
18. Berthod G, Lazor R, Letovanec I, et al: Pulmonary sarcoid-like granulomatosis induced by ipilimumab. J Clin Oncol 30:e156-e159, 2012
19. Hodi FS, Butler M, Oble DA, et al: Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A 105:3005-3010, 2008
20. Thajudeen B, Koppula S, Madhrira M: Ipilimumab induced granulomatous interstitial nephritis. National Kidney Foundation Spring Clinical Meetings, Washington, DC, May 9-13, 2012 (abstr 31)
21. Sumimoto H, Imabayashi F, Iwata T, et al: The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J Exp Med 203:1651-1656, 2006
22. Joseph RW, Sullivan RJ, Harrell R, et al: Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma. J Immunother 35:66-72, 2012
23. Weber JS, Dummer R, de Pril V, et al: Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer 119:1675-1682, 2013
24. Weber JS, Kähler KC, Hauschild A: Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 30:2691-2697, 2012
25. Hodi FS, O'Day SJ, McDermott DF, et al: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711-723, 2010